Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Harnessing pre-existing immunity to enhance the immunogenicity of an adjuvant-free, immuno-targeting subunit vaccine against SARS-CoV-2
FY 2021-22
Summary
Vaccination is a key public health measure for the prevention and control of infectious diseases. Against rapidly changing pathogens, protein subunit vaccines offer efficiencies in development and production alongside an excellent safety profile, allowing for use across diverse populations, including immunocompromised individuals. The limited immunogenicity of purified protein antigens necessitates the use of immunostimulatory adjuvants; however, adjuvant addition requires antigen-specific optimization, and often leads to increased reactogenicity. Therefore, adjuvant-independent approaches to immune stimulation are important for the development of next-generation vaccine platforms. Both targeted antigen delivery and the inclusion of broadly reactive T helper epitopes have been shown to enhance the magnitude and durability of immune responses. To this end, the goal of my research is to determine the efficacy of using T helper epitope induced memory recall responses as a means to increase vaccine immunogenicity. Specifically, rabbits that have been pre-immunized with a tetanus and diphtheria vaccine will be subsequently administered an immune-cell targeting, adjuvant-free protein subunit vaccine against SARS-CoV-2, containing a universal memory T cell epitope derived from tetanus and diphtheria toxoids. To examine the immune response following vaccination, antibody titres, antibody neutralization potency, and T cell function will be measured by enzyme linked-immunosorbent assays, surrogate- and pseudo-virus neutralization, and functional T cell assays, respectively. Collectively, this work will expand our understanding of adjuvant-independent immune responses in the context of pre-existing immunity and inform the design of next-generation protein subunit vaccines.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
467139
Name
Sun Eric
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Harnessing pre-existing immunity to enhance the immunogenicity of an adjuvant-free, immuno-targeting subunit vaccine against SARS-CoV-2
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adjuvant Independent; Antibodies; Antigen Delivery; Immune Memory; Immune Stimulation; Immunogen Design; Preclinical; Sars-Cov-2; Vaccine Development; Vaccines
Abstract
Vaccination is a key public health measure for the prevention and control of infectious diseases. Against rapidly changing pathogens, protein subunit vaccines offer efficiencies in development and production alongside an excellent safety profile, allowing for use across diverse populations, including immunocompromised individuals. The limited immunogenicity of purified protein antigens necessitates the use of immunostimulatory adjuvants; however, adjuvant addition requires antigen-specific optimization, and often leads to increased reactogenicity. Therefore, adjuvant-independent approaches to immune stimulation are important for the development of next-generation vaccine platforms. Both targeted antigen delivery and the inclusion of broadly reactive T helper epitopes have been shown to enhance the magnitude and durability of immune responses. To this end, the goal of my research is to determine the efficacy of using T helper epitope induced memory recall responses as a means to increase vaccine immunogenicity. Specifically, rabbits that have been pre-immunized with a tetanus and diphtheria vaccine will be subsequently administered an immune-cell targeting, adjuvant-free protein subunit vaccine against SARS-CoV-2, containing a universal memory T cell epitope derived from tetanus and diphtheria toxoids. To examine the immune response following vaccination, antibody titres, antibody neutralization potency, and T cell function will be measured by enzyme linked-immunosorbent assays, surrogate- and pseudo-virus neutralization, and functional T cell assays, respectively. Collectively, this work will expand our understanding of adjuvant-independent immune responses in the context of pre-existing immunity and inform the design of next-generation protein subunit vaccines.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sun, Eric
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~